Cargando…
Crosstalk between endocannabinoid and immune systems: a potential dysregulation in depression?
BACKGROUND: The endocannabinoid (eCB) system, an endogenous lipid signaling system, appears to be dysregulated in depression. The role of endocannabinoids (eCBs) as potent immunomodulators, together with the accumulating support for a chronic low-grade inflammatory profile in depression, suggests a...
Autores principales: | Boorman, Emily, Zajkowska, Zuzanna, Ahmed, Rumsha, Pariante, Carmine M., Zunszain, Patricia A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828487/ https://www.ncbi.nlm.nih.gov/pubmed/26483037 http://dx.doi.org/10.1007/s00213-015-4105-9 |
Ejemplares similares
-
The role of circulatory systemic environment in predicting interferon-alpha–induced depression: The neurogenic process as a potential mechanism
por: Borsini, Alessandra, et al.
Publicado: (2019) -
Crosstalk between the endocannabinoid and mid-brain dopaminergic systems: Implication in dopamine dysregulation
por: Kibret, Berhanu Geresu, et al.
Publicado: (2023) -
Depression pathogenesis and treatment: what can we learn from blood mRNA expression?
por: Hepgul, Nilay, et al.
Publicado: (2013) -
Characterizing anhedonia: A systematic review of neuroimaging across the subtypes of reward processing deficits in depression
por: Borsini, Alessandra, et al.
Publicado: (2020) -
Glucocorticoid Resistance: Is It a Requisite for Increased Cytokine Production in Depression? A Systematic Review and Meta-Analysis
por: Perrin, Andrew J., et al.
Publicado: (2019)